March 11, 2022
2 min watch
Save
VIDEO: Rhopressa increases episcleral venous blood flow
Issue: April 25, 2022
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
NASHVILLE, Tenn. — At the American Glaucoma Society meeting, Osamah Saeedi, MD, discusses results from a study exploring the effect of Rhopressa (netarsudil ophthalmic solution 0.02%, Aerie Pharmaceuticals) on episcleral venous flow rates.